About

SeeTrue Technology is a Life Sciences - Biotech Startup. It is focused on developing a line of microcapillary, easy-to-use needles that improve precision and outcomes of microinjections.

Learn about SeeTrue needles and microinjections

​

Awards

• Mar., 2020 - NSF Small Business Technology Transfer (STTR) Phase-I award,

• Feb., 2020 - Maryland Industrial Partnerships (MIPS) Phase-I award,

• Mar., 2019 - Small Business Innovation Research (SBIR) Phase-I award from the National Institute of Health, NIH
   

Start-up Programs

• Nationwide - One of the start-ups, chosen by NSF to participate in the  National Innovation Corps (I-Corps) program .

• Wash. DC - One of the start-ups selected to participate in the AccelerateDC and AccelerateGO programs in George Washington University (GWU).

Check out Resources for Biotech Startups

​

Founder & CEO, Kinneret Rand-Yadin

Kinneret Rand-Yadin is a PhD scientist with experience across a diverse range of research platforms.  Kinneret possesses an extensive industry experience in product development, assay and systems development, product transfer, and manufacturing with emphasis on process improvement, quality, and productivity, in a GLP and GMP environments. Kinneret gained familiarity with clinical trial operations/procedures, FDA regulatory and submission documentation processes, and clinical trial risk assessment protocols.
Meet our Team

​

Our Philosophy, Startup Community and Win-Win for All

We believe that sharing knowledge and wisdom is beneficial in finding solutions that help everybody. From idea to a funded Startup, SeeTrue Technology had received a lot of assistance, advice and mentorship. We offer our experience and information – Startup Community, to the interested communities, Biotech, startups, researchers/medical staff doing microinjections, investors, and anybody.
Join the Biotech Startup Community

​

Team Up With Us
 

​

​

• Tell us about the difficulties you experience with microinjections

• Volunteer to try out the SeeTrue needles

• Follow our progress for your research needs or business development opportunities

​